Drug intelligence / Profile preview

mRNA-Nipah Virus vaccine

Development stage: Preclinical
Lead developer: Gennova Biopharmaceuticals
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, mRNA Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

mRNA-Nipah Virus vaccine is an investigational mRNA-based vaccine developed by Vernagen for the prevention of Nipah virus infection. The vaccine utilizes mRNA technology to instruct host cells to synthesize Nipah virus antigens, which then elicit a protective immune response. As of early 2024, the vaccine is in the preclinical stage, specifically undergoing animal efficacy testing in collaboration with Duke-NUS Medical School in Singapore. This candidate is part of Vernagen's broader mRNA vaccine pipeline targeting emerging infectious diseases and utilizes a platform designed to provide rapid response capabilities against viral pathogens.

Other names: mRNA-Nipah Virus vaccineVernagen Nipah vaccine

Targets

NiV (Nipah virus)

Beyond the preview

Go deeper on mRNA-Nipah Virus vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA-Nipah Virus vaccine.

Explore the full profile